Evaluation of Recombinant Cholera Toxin B Subunit as a Nasal Mucosal Adjuvant.
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 1998-10-07
著者
-
Yasuda Yoko
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
Kozuka Satoshi
Department Of Microbiology Nagoya City University Medical School
-
GOTO Norihisa
Dept. of Safety Res. on Biologics, National Institute of Infectious Disdases
-
Goto Norihisa
Department Of Safety Research On Blood And Biological Products
-
Tochikubo Kunio
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
Isaka Masanori
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
TANIGUCHI Tooru
Department of Microbiology, Nagoya City University Medical School
-
Taniguchi Tooru
Department Of Microbiology Nagoya City University Medical School
-
MATANO Keiko
Department of Microbiology, Nagoya City University Medical School
-
MAEYAMA Jun-ichi
Dept. of Safety Research on Biologics, National Institute of Infectious Diseases
-
ISAKA Masanori
Dept. of Microbiology, Nagoya City University Medical School
-
TANIGUCHI Tooru
Dept. of Microbiology, Nagoya City University Medical School
-
KOZUKA Satoshi
Dept. of Microbiology, Nagoya City University Medical School
-
YASUDA Yoko
Dept. of Microbiology, Nagoya City University Medical School
-
TOCHIKUBO Kunio
Dept. of Microbiology, Nagoya City University Medical School
-
MATANO Keiko
Dept.of Microbiology, Nagoya City University Medical School
-
MIURA Yutaka
Dept.of Microbiology, Nagoya City University Medical School
-
Taniguchi Taketoshi
Laboratory Of Molecular Biology Medical Research Center Kochi Medical School
-
Matano Keiko
Department Of Microbiology Nagoya City University Medical School
-
Miura Yutaka
Dept.of Microbiology Nagoya City University Medical School
-
Maeyama Jun-ichi
Department Of Safety Research On Blood And Biological Products National Institute Of Infectious Dise
関連論文
- Transmembrane Chondroitin Sulfate Proteoglycans in the Developing Brain : Involvements in Signal Transduction as Well as in Cell Adhesion
- Cloning and chromosomal mapping of the human gene of neuroglycan C (NGC), a neural transmembrane chondroitin sulfate proteoglycan with an EGF module
- THE ACTION MECHANISMS OF UVA-1 (340-400NM) PHOTOTHERAPY FOR CUTANEOUS T CELL LYMPHOMA
- INVESTIGATIONS ON THE SENSITIVITY OF ISOLATED STRAINS OF SHIGELLA FLEXNERI 2a FROM MASS OUTBREAKS OF DYSENTRY TO COLICINS OF THE SHIGELLA SONNEI
- INVESTIGATIONS ON THE SENSITIVITY OF ISOLATED STRAINS OF SHIGELLA FLEXNERI 3a FROM EPIDEMICS OF DYSENTERY TO COLICINS OF THE SHIGELLA SONNEI
- COLICIN TYPES OF SHIGELLA SONNEI ISOLATED FROM EPIDEMICS OF DYSENTERY OCCURRED IN AICHI PREFECTURE OF JAPAN
- 2B-23 Mechanism of the Allergic Reactions of Guinea Pigs Induced by Human Interferon Product
- Recombinant Cholera Toxin B Subunit Activates Dendritic Cells and Enhances Antitumor Immunity
- Alteration of endogenous corticosteroids and catecholamines in allergen-induced eosinophilic inflammation in Brown Norway rats
- Mechanism for Maintenance of Dominant T Helper 1 Immune Responses in Lewis Rats
- The Gene Encoding the Prepilin Peptidase lnvolved in Biosynthesis of Pilus Colonization Factor Antigen III (CFA/III) of Human Enterotoxigenic Escherichia coli
- Genetic Background Determines Sensitivity to the Inhibitory Function of NO on T Cell Proliferation and the Amounts of NO Production Mediated through IFN-γ
- Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice
- Effects of Recombinant Cholera Toxin B Subunit (rCTB) on Cellular Immune Responses : Enhancement of Delayed-Type Hypersensitivity Following Intranasal Co-Administration of Mycobacterium bovis-BCG with rCTB
- Effects of Recombinant Cholera Toxin B Subunit on IL-1β Production by Macrophages In Vitro
- Cytokine Responses to Recombinant Cholera Toxin B Subunit Produced by Bacillus brevis as a Mucosal Adjuvant
- O-25 Adjuvanticity and Safety of rCTB as a Nasal Mucosal Adjuvant.(Proceedings of the 27th Annual Meeting)
- Evaluation of Recombinant Cholera Toxin B Subunit as a Nasal Mucosal Adjuvant.